3rd Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2014 $200,000 Replaced
3rd Quarter - Amendment Sep 21, 2015 $100,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3742 (113th)

Medicare/Medicaid MMM

S.672, Medicare Safe Needle Disposal Coverage Act of 2013

LobbyistCovered position, as disclosed
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 672 (113th)

Budget/Appropriations BUD

NIH funding

LobbyistCovered position, as disclosed
JENNIFER M LURAY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.